In this series of articles, Aaron Green sits down and interviews a number of industry scientists and executives leading cannabis formulation companies. In Part 2, Green chats with Jesse Lopez, CEO and Founder of Geocann, a global cannabis organization based in Fort Collins, Colorado with technical formulation expertise and the exclusive global rights to multi-patented drug delivery system technologies.
The FDA issued warning letters to two companies this month, alleging FD&C Act violations stemming from marketing new drugs without approval. Companies marketing CBD products should be careful not to market OTC drugs containing CBD.
The post FDA Issues Warning Letters on Marketing and Sale of OTC CBD Products appeared first on Cannabis Industry Journal.
In a press release published last week, the two companies announced they have entered an agreement for Jazz to acquire GW Pharma, the producer of the only FDA-approved CBD medication Epidiolex, for a total of $7.2 billion.